Relationship between baseline clinical characteristics and efficacy of lusutrombopag in thrombocytopenic patients with chronic liver disease: post hoc analysis of two placebo-controlled phase 3 trials-Reference-Cited by-同舟云学术

Relationship between baseline clinical characteristics and efficacy of lusutrombopag in thrombocytopenic patients with chronic liver disease: post hoc analysis of two placebo-controlled phase 3 trials

Published:2021-12-22 Issue:2 Volume:38 Page:303-310
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Tanaka Katsuaki¹^ORCID,Baba Takamichi²,Yoshida Manami³,Iguchi Motofumi³,Sonoyama Takuhiro⁴,Fukuhara Takahiro⁵,Kano Takeshi⁶

Affiliation:

1. Department of Gastroenterology, Japanese Red Cross Society Hadano Hospital, Kanagawa, Japan

2. Biostatistics Center, Shionogi & Co., Ltd., Osaka, Japan

3. Medical Affairs, Shionogi & Co., Ltd., Osaka, Japan

4. Medical Science, Shionogi & Co., Ltd., Osaka, Japan

5. Clinical Development, Shionogi & Co., Ltd., Osaka, Japan

6. Project Management, Shionogi & Co., Ltd., Osaka, Japan

Funder

Shionogi & Co., Ltd., Osaka Japan

Shionogi

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2021.2012964

Reference29 articles.

1. Thrombocytopenia associated with chronic liver disease

2. Incidence of Bleeding Following Invasive Procedures in Patients With Thrombocytopenia and Advanced Liver Disease

3. Platelet Transfusion for Patients With Cancer: Clinical Practice Guidelines of the American Society of Clinical Oncology*

4. Current issues with platelet transfusion in patients with cancer

5. Non-infectious complications of transfusion therapy

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Final Results from the First European Real-World Experience on Lusutrombopag Treatment in Cirrhotic Patients with Severe Thrombocytopenia: Insights from the REAl-World Lusutrombopag Treatment in ITalY Study;Journal of Clinical Medicine;2024-07-06

2. A single course of lusutrombopag for multiple invasive procedures in cirrhosis-associated thrombocytopenia: A case series;Medicine;2022-11-04

3. Activation of Nrf2/HO-1 signaling: An important molecular mechanism of herbal medicine in the treatment of atherosclerosis via the protection of vascular endothelial cells from oxidative stress;Journal of Advanced Research;2021-12